The potential for therapy of immune disorders with gene therapy (Q34114577)

31 July 2017

1 reference

title

The potential for therapy of immune disorders with gene therapy (English)

1 reference

31 July 2017

0 references

Candotti F

1

1 reference

31 July 2017

publication date

1 December 2000

1 reference

Pediatric Clinics of North America

31 July 2017

published in

1 reference

31 July 2017

volume

47

1 reference

31 July 2017

issue

6

1 reference

31 July 2017

page(s)

1389-1407

1 reference

Human gene marker/therapy clinical protocols

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970277-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970277-7

Human immunodeficiency virus type 2 lentivirus vectors for gene transfer: expression and potential for helper virus-free packaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970277-7

Identification of the homologous beige and Chediak-Higashi syndrome genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970277-7

Correction of respiratory burst activity in X-linked chronic granulomatous cells to therapeutically relevant levels after gene transfer into bone marrow CD34+ cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970277-7

A newly discovered class of human hematopoietic cells with SCID-repopulating activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970277-7

The ADA human gene therapy clinical protocol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970277-7

T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970277-7

Gene therapy in peripheral blood lymphocytes and bone marrow for ADA- immunodeficient patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970277-7

Thymic lymphoproliferative disease after successful correction of CD40 ligand deficiency by gene transfer in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970277-7

Human severe combined immunodeficiency: genetic, phenotypic, and functional diversity in one hundred eight infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970277-7

Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970277-7

Virus-specific immunity after gene therapy in a murine model of severe combined immunodeficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970277-7

Restoration of lymphocyte function in Janus Kinase 3-deficient mice by retroviral-mediated gene transfer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970277-7

Retrovirus-mediated WASP gene transfer corrects defective actin polymerization in B cell lines from Wiskott-Aldrich syndrome patients carrying 'null' mutations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970277-7

In vitro correction of JAK3-deficient severe combined immunodeficiency by retroviral-mediated gene transduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970277-7

Stable transduction of quiescent CD34(+)CD38(-) human hematopoietic cells by HIV-1-based lentiviral vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970277-7

Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970277-7

Lymphocytes as cellular vehicles for gene therapy in mouse and man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970277-7

The CD34 molecule and hematopoietic progenitor cell studies--a challenge in clinical medicine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970277-7

European experience of bone-marrow transplantation for severe combined immunodeficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970277-7

Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970277-7

Gene therapy using retroviral vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970277-7

Expression of human Wiskott-Aldrich syndrome protein in patients' cells leads to partial correction of a phenotypic abnormality of cell surface glycoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970277-7

The use of gene-modified tumor-infiltrating lymphocytes for cancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970277-7

Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970277-7

The current status of gene therapy using hematopoietic stem cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970277-7

T lymphocytes with a normal ADA gene accumulate after transplantation of transduced autologous umbilical cord blood CD34+ cells in ADA-deficient SCID neonates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970277-7

An in vivo animal model of gene therapy for leukocyte adhesion deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970277-7

The molecular basis of X-linked severe combined immunodeficiency: the role of the interleukin-2 receptor gamma chain as a common gamma chain, gamma c.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970277-7

Clinical spectrum of X-linked hyper-IgM syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970277-7

Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970277-7

Prolonged production of NADPH oxidase-corrected granulocytes after gene therapy of chronic granulomatous disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970277-7

Retrovirus packaging cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970277-7

Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970277-7

Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970277-7

Gene therapy for AIDS using retroviral mediated gene transfer to deliver HIV-1 antisense TAR and transdominant Rev protein genes to syngeneic lymphocytes in HIV-1 infected identical twins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970277-7

In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970277-7

Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970277-7

Efficient gene transfer into human cord blood CD34+ cells and the CD34+CD38- subset using highly purified recombinant adeno-associated viral vector preparations that are free of helper virus and wild-type AAV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970277-7

Biology of CD34+CD38- cells in lymphohematopoiesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970277-7

Signaling via IL-2 and IL-4 in JAK3-deficient severe combined immunodeficiency lymphocytes: JAK3-dependent and independent pathways.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970277-7

Gene transfer vectors derived from equine infectious anemia virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970277-7

Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970277-7

Lymphoid development and function in X-linked severe combined immunodeficiency mice after stem cell gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970277-7

Novel human immunodeficiencies reveal the essential role of type-I cytokines in immunity to intracellular bacteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970277-7

Efficient transduction of nondividing human cells by feline immunodeficiency virus lentiviral vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970277-7

Transduction of nondividing cells using pseudotyped defective high-titer HIV type 1 particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970277-7

Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970277-7

The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970277-7

RAG mutations in human B cell-negative SCID.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970277-7

Peripheral blood progenitors as a target for genetic correction of p47phox-deficient chronic granulomatous disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970277-7

Severe combined immunodeficiency: a retrospective single-center study of clinical presentation and outcome in 117 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970277-7

Reconstitution of T cell receptor signaling in ZAP-70-deficient cells by retroviral transduction of the ZAP-70 gene.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970277-7

HIV, but not murine leukemia virus, vectors mediate high efficiency gene transfer into freshly isolated G0/G1 human hematopoietic stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970277-7

Partial V(D)J recombination activity leads to Omenn syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970277-7

Expression of human CD18 in murine granulocytes and improved efficiency for infection of deficient human lymphoblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970277-7

KDR receptor: a key marker defining hematopoietic stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970277-7

Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970277-7

High-titer packaging cells producing recombinant retroviruses resistant to human serum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970277-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970277-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0031-3955(05)70277-7

1 reference

31 July 2017

1 reference